Search Results for: newsflash-allergy
New York researchers at Mount Sinai are easing the relentless itch of eczema with a new drug. Dubbed a “breakthrough” therapy by the FDA, it treats eczema’s source rather than just its symptoms.
In trials, Viaskin Peanut allowed some participants to tolerate 10 times more peanut protein than at the outset.
Chance of developing peanut allergy reduced 70 to 80 percent in high-risk babies. New guidelines expected.
Emergency auto-injectors were used in more than 900 cases of anaphylaxis in U.S. schools last academic year.
Researchers in Australia have introduced a game-changing idea in the hunt for a peanut allergy cure. They combined a large daily dose of specific probiotics with oral immunotherapy to find out whether this would effectively treat peanut allergy.